Диссертация (1174245), страница 20
Текст из файла (страница 20)
A. Schmitt, D. R. Wekstein, W. R. Markesbery // J. Neuropathol.Exp. Neurol. – 1999. – Т. 58 – № 4 – P. 376–388.128. Dubois, B. Revising the definition of Alzheimer’s disease: a new lexicon / B.Dubois, H. H. Feldman, C. Jacova, J. L. Cummings, S. T. DeKosky, P. Barberger-Gateau,A. Delacourte, G.
Frisoni, N. C. Fox, D. Galasko // Lancet Neurol. – 2010. – Т. 9 – № 11– P. 1118-1127.129. Dubois, B. The FAB: a frontal assessment battery at bedside / B. Dubois, A.Slachevsky, I. Litvan, B. Pillon // Neurology. – 2000. – Т. 55 – № 11 – P. 1621-1626.130. Eskildsen, S.F. Increased cortical capillary transit time heterogeneity inAlzheimer’s disease: a DSC-MRI perfusion study / S. F.
Eskildsen, L. Gyldensted, K.120Nagenthiraja, R. B. Nielsen, M. B. Hansen, R. B. Dalby, J. Frandsen, A. Rodell, C.Gyldensted, S. N. Jespersen // Neurobiol. Aging. – 2017. – Т. 50 – P. 107–118.131. Farecki, M.-L. Characteristics of type 1 and 2 CNV in exudative AMD inOCT-Angiography / M.-L. Farecki, M. Gutfleisch, H. Faatz, K. Rothaus, B. Heimes, G.Spital, A.
Lommatzsch, D. Pauleikhoff // Graefe’s Arch. Clin. Exp. Ophthalmol. – 2017.– Т. 255 – № 5 – P. 913-921.132. Feihl, F. Hypertension and microvascular remodelling / F. Feihl, L. Liaudet,B. I. Levy, B. Waeber // Cardiovasc. Res. – 2008. – Т. 78 – № 2 – P. 274-285.133.
Fiandaca, M.S. Identification of preclinical Alzheimer’s disease by a profileof pathogenic proteins in neurally derived blood exosomes: A case-control study / M. S.Fiandaca, D. Kapogiannis, M. Mapstone, A. Boxer, E. Eitan, J. B. Schwartz, E. L. Abner,R. C. Petersen, H. J.
Federoff, B. L. Miller, E. J. Goetzl // Alzheimer’s Dement. – 2015.– Т. 11 – № 6 – P. 600-607.134. Folstein, M.F. “Mini-mental state”: a practical method for grading thecognitive state of patients for the clinician / M. F. Folstein, S. E. Folstein, P. R. McHugh// J. Psychiatr. Res. – 1975. – Т. 12 – № 3 – P. 189-198.135. Frost, S. Retinal amyloid fluorescence imaging predicts cerebral amyloidburden and alzheimer’s disease / S. Frost, Y. Kanagasingam, L.
Macaulay, M. KoronyoHamaoui, Y. Koronyo, D. Biggs, S. Verdooner, K. Black, K. Taddei, T. Shah //Alzheimer’s Dement. J. Alzheimer’s Assoc. – 2014. – Т. 10 – № 4 – P. 234-236.136. Fuster, J.M. Upper processing stages of the perception–action cycle / J. M.Fuster // Trends Cogn. Sci. – 2004. – Т. 8 – № 4 – P. 143-145.137. Gao, L. Abnormal retinal nerve fiber layer thickness and macula lutea inpatients with mild cognitive impairment and Alzheimer’s disease / L. Gao, Y. Liu, X. Li,Q.
Bai, P. Liu // Arch. Gerontol. Geriatr. – 2015. – Т. 60 – № 1 – P. 162-167.138. Garcia-Martin, E. Fibromyalgia is correlated with retinal nerve fiber layerthinning / E. Garcia-Martin, J. Garcia-Campayo, M. Puebla-Guedea, F. J. Ascaso, M.121Roca, F. Gutierrez-Ruiz, E. Vilades, V. Polo, J.
M. Larrosa, L. E. Pablo, M. Satue // Int.Ophthalmol. – 2016. – Т. 11 – № 9 - P. 25-28.139. Gasser, P. Ocular vasospasm: a risk factor in the pathogenesis of low-tensionglaucoma / P. Gasser // Int. Ophthalmol. – 1989. – Т. 13 – № 4 – P. 281-290.140. Gharbiya, M. Choroidal thinning as a new finding in Alzheimer’s Disease:Evidence from enhanced depth imaging spectral domain optical coherence tomography /M. Gharbiya, A.
Trebbastoni, F. Parisi, S. Manganiello, F. Cruciani, F. D’Antonio, U. DeVico, L. Imbriano, A. Campanelli, C. De Lena // J. Alzheimer’s Dis. – 2014. – Т. 40 – №4 – P. 907-917.141. Gilmore, G.C. Contrast sensitivity in Alzheimer’s disease: a 1-yearlongitudinal analysis. / G. C. Gilmore, P. J. Whitehouse // Optom. Vis. Sci. Off. Publ.Am. Acad. Optom. – 1995. – Т. 72 – № 2 – P. 83–91.142. Golzan, S.M. Retinal vascular and structural changes are associated withamyloid burden in the elderly: ophthalmic biomarkers of preclinical Alzheimer’s disease/ S. M. Golzan, K. Goozee, D.
Georgevsky, A. Avolio, P. Chatterjee, K. Shen, V. Gupta,R. Chung, G. Savage, C. F. Orr // Alzheimers. Res. Ther. – 2017. – Т. 9 – № 1 – P. 13.143. Granholm, E. Tropicamide effects on pupil size and pupillary light reflexes inAlzheimer’s and Parkinson’s disease / E. Granholm, S. Morris, D. Galasko, C. Shults, E.Rogers, B. Vukov // Int. J. Psychophysiol. – 2003. – Т. 47 – № 2 – P. 95–115.144. Grosso, A. Hypertensive retinopathy revisited: Some answers, more questions/ A.
Grosso, F. Veglio, M. Porta, F. M. Grignolo, T. Y. Wong // Br. J. Ophthalmol. –2005. – Т. 89 – № 12 – P. 1646-1654.145. Günes, A. Evaluation of retinal nerve fiber layer thickness in Alzheimerdisease using spectral-domain optical coherence tomography / A. Günes, S. Demirci, L.Tök, Ö. Tök, S. Demirci // Turkish J.
Med. Sci. – 2015. – Т. 45 – № 5 – P. 1094-1097.146. Guo, L. Targeting amyloid-β in glaucoma treatment / L. Guo, T. E. Salt, V.Luong, N. Wood, W. Cheung, A. Maass, G. Ferrari, F. Russo-Marie, A. M. Sillito, M. E.122Cheetham // Proc. Natl. Acad. Sci. – 2007. – Т. 104 – № 33 – P. 13444-13449.147.
Gupta, N. Retinal tau pathology in human glaucomas / N. Gupta, J. Fong, L.C. Ang, Y. H. Yücel // Can. J. Ophthalmol. – 2008. – Т. 43 – № 1 – P. 53-60.148. Gupta, N. Glaucoma as a neurodegenerative disease / N. Gupta, Y. H. Yücel// Curr. Opin. Ophthalmol. – 2007. – Т. 18 – № 2 – P. 110–114.149. Hane, F.T.
Recent progress in Alzheimer’s disease research, part 1: Pathology/ F. T. Hane, B. Y. Lee, Z. Leonenko // J. Alzheimer’s Dis. – 2017. – Т. 57 – № 1 – P. 1–28.150. Hardy, J. Toward Alzheimer therapies based on genetic knowledge / J. Hardy// Annu. Rev. Med. – 2004. – Т. 55 – P. 15–25.151. Hardy, J. A genetic outline of the pathways to cell death in Alzheimer’sdisease, Parkinson’s disease, frontal dementias and related disorders / J. Hardy //Neurodegener. Dis.
Neurobiol. Pathog. Ther. – 2005. – T.97 - №6 - P. 222.152. He, X.-F. Optical coherence tomography assessed retinal nerve fiber layerthickness in patients with Alzheimer’s disease: a meta-analysis. / X.-F. He, Y.-T. Liu, C.Peng, F. Zhang, S. Zhuang, J.-S. Zhang // Int. J. Ophthalmol. – 2012. – Т. 5 – № 3 – P.1–5.153. Herrero, R. Progressive degeneration of the retinal nerve fiber layer in patientswith multiple sclerosis / R.
Herrero, E. Garcia-Martin, C. Almarcegui, J. R. Ara, D.Rodriguez-Mena, J. Martin, S. Otin, M. Satue, L. E. Pablo, F. J. Fernandez // Invest.Ophthalmol. Vis. Sci. – 2012. – Т. 53 – № 13 – P. 8344-8349.154. Hinton, D.R. Optic-Nerve Degeneration in Alzheimer’s Disease / D. R.Hinton, A. A. Sadun, J. C. Blanks, C. A. Miller // N. Engl. J. Med. – 1986. – Т. 315 – №8 – P.485-487.155. Hof, P.R. Quantitative analysis of a vulnerable subset of pyramidal neuronsin Alzheimer’s disease: I.
Superior frontal and inferior temporal cortex / P. R. Hof, J. H.Morrison, K. Cox // J. Comp. Neurol. – 1990. – Т. 301 – № 1 – P. 44–54.123156. Idiaquez, J. Cholinergic supersensitivity of the iris in Alzheimer’s disease. / J.Idiaquez, G. Alvarez, R. Villagra, R. A. San Martin // J. Neurol. Neurosurg.
Psychiatry –1994. – Т. 57 – № 12 – P. 1544.157. Iqbal, K. Mechanisms of tau-induced neurodegeneration / K. Iqbal, F. Liu, C.X. Gong, A. del C. Alonso, I. Grundke-Iqbal // Acta Neuropathol. – 2009. – Т. 118 – №1 – P. 53–69.158. Iseri, P.K. Relationship between cognitive impairment and retinalmorphological and visual functional abnormalities in Alzheimer disease / P. K. Iseri, Ö.Altinas, T. Tokay, N. Yüksel // J. neuro-ophthalmology – 2006. – Т. 26 – № 1 – P. 18–24.159. Jack Jr, C.R. Introduction to the recommendations from the National Instituteon Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’sdisease / C.
R. Jack Jr, M. S. Albert, D. S. Knopman, G. M. McKhann, R. A. Sperling,M. C. Carrillo, B. Thies, C. H. Phelps // Alzheimer’s Dement. – 2011. – Т. 7 – № 3 – P.257–262.160. Janciauskiene, S. Alzheimer’s peptide: A possible link between glaucoma,exfoliation syndrome and Alzheimer’s disease / S. Janciauskiene, T. Krakau // ActaOphthalmol. Scand.
– 2001. – Т. 79 – № 3 – P. 328–329.161. Jellinger, К.A., Bancher С. Neuropathology of Alzheimer's disease: a criticalupdate. // J Neural Transm. Suppl. 1998. - T/54. - P. 77-95162. Jong, F. de Retinal vascular caliber and risk of dementia / F. de Jong, E.Schrijvers, M. Ikram, P. Koudstaal, P. de Jong, A. Hofman, J. Vingerling, M.
Breteler //Neurology – 2011. – Т. 76 – P. 816-821.163. Kaarniranta, K. Age-related macular degeneration (AMD): Alzheimer’sdisease in the eye? / K. Kaarniranta, A. Salminen, A. Haapasalo, H. Soininen, M. Hiltunen// J. Alzheimer’s Dis. – 2011. – Т. 24 – № 4 – P. 615–631.164. Kannel, W.B. Systolic blood pressure, arterial rigidity, and risk of stroke: the124Framingham study / W. B. Kannel, P. A. Wolf, D. L. McGee, T.
R. Dawber, P.McNamara, W. P. Castelli // Jama – 1981. – Т. 245 – № 12 – P. 1225-1229.165. Kirbas, S. Retinal Nerve Fiber Layer Thickness in Parkinson Disease / S.Kirbas, K. Turkyilmaz, A. Tufekci, M. Durmus // J. Neuro-Ophthalmology. – 2013. – Т.33 – № 1 - P. 20-23.166. Kirby, E. Visual impairment in Alzheimer’s disease: a critical review / E.Kirby, S. Bandelow, E.
Hogervorst // J. Alzheimer’s Dis. – 2010. – Т. 21 – № 1 – P. 15–34.167. Kivipelto, M. Midlife vascular risk factors and Alzheimer’s disease in laterlife: longitudinal, population based study / M. Kivipelto, E.-L. Helkala, M. P. Laakso, T.Hänninen, M. Hallikainen, K. Alhainen, H. Soininen, J. Tuomilehto, A. Nissinen // J.Alzheimer’s Dis. – 2001. – Т.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
